IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$473.28 USD
-1.37 (-0.29%)
Updated Oct 10, 2024 04:00 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Income Statements
Fiscal Year end for IDEXX Laboratories, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 |
Cost Of Goods | 1,471 | 1,363 | 1,326 | 1,136 | 1,041 |
Gross Profit | 2,190 | 2,004 | 1,889 | 1,571 | 1,366 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,093 | 1,106 | 957 | 877 | 813 |
Income After Depreciation & Amortization | 1,097 | 899 | 932 | 695 | 553 |
Non-Operating Income | 6 | 1 | 0 | 1 | 0 |
Interest Expense | 42 | 40 | 30 | 33 | 31 |
Pretax Income | 1,061 | 860 | 903 | 662 | 522 |
Income Taxes | 216 | 181 | 158 | 80 | 94 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 845 | 679 | 745 | 582 | 428 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 845 | 679 | 745 | 582 | 428 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,212 | 1,011 | 1,037 | 791 | 641 |
Depreciation & Amortization (Cash Flow) | 115 | 112 | 105 | 96 | 88 |
Income After Depreciation & Amortization | 1,097 | 899 | 932 | 695 | 553 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 83.98 | 84.60 | 86.57 | 86.72 | 87.54 |
Diluted EPS Before Non-Recurring Items | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 |
Diluted Net EPS (GAAP) | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 |
Fiscal Year end for IDEXX Laboratories, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 1,003.58 | 964.10 | 901.60 | 915.53 |
Cost Of Goods | NA | 384.42 | 371.03 | 375.43 | 367.55 |
Gross Profit | NA | 619.16 | 593.07 | 526.17 | 547.98 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 355.36 | 294.12 | 280.86 | 272.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 263.80 | 298.95 | 245.31 | 275.28 |
Non-Operating Income | NA | 3.35 | 4.43 | 3.63 | 1.26 |
Interest Expense | NA | 8.10 | 7.91 | 9.27 | 8.65 |
Pretax Income | NA | 259.06 | 295.48 | 239.67 | 267.89 |
Income Taxes | NA | 55.76 | 59.90 | 45.15 | 55.66 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 203.30 | 235.58 | 194.52 | 212.23 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 203.30 | 235.58 | 194.52 | 212.23 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 83.39 | 83.96 | 83.93 | 83.99 |
Diluted EPS Before Non-Recurring Items | NA | 2.44 | 2.81 | 2.32 | 2.53 |
Diluted Net EPS (GAAP) | NA | 2.44 | 2.81 | 2.31 | 2.53 |